KUNTUO, an IQVIA company

昆拓KUNTUO is a wholly-owned subsidiary of IQVIA(NYSE:IQV) and a CRO specially established for the Chinese local market. IQVIA(NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. As the China local solution of IQVIA, 昆拓KUNTUO fully accepts IQVIA's quality and compliance management. Its main business is to provide full-process clinical trial services in China, covering project management, clinical monitoring, data management, statistics, site management, etc. It also provides regulatory interpretation, medical support, expert consultation, and medical statistical support during the early strategic formulation stage of clinical research projects. Since its establishment in 2011, it has provided comprehensive clinical research services for many international and domestic pharmaceutical companies, medical device, and IVD companies, involving multiple therapeutic areas such as oncology, psychiatry, and cardiovascular diseases, as well as various medical devices and in vitro diagnostic reagent fields.